Nesa Medtech
2 known investors
Nesa Medtech develops GYIDE, a minimally invasive, uterus-preserving medical device that uses a guidance and planning system to deliver treatment that shrinks uterine fibroids without cutting or suturing. The company targets women's health, offering an alternative to existing surgical and non-surgical treatments for uterine fibroids.